The largest database of trusted experimental protocols

18 protocols using human cd19 microbeads

1

Isolation of CD19+ B cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were obtained after the approval from the Beijing Institute of Basic Medical Sciences, consent from 9 normal human subjects, 3 patients with MM, and 6 patients with SLE from Clinical Trial Center (Beijing 301 Hospital). CD19+ B cells were isolated using human CD19 MicroBeads (Cat No. 130-090-880, Miltenyi Biotec).
+ Open protocol
+ Expand
2

Isolation and Purification of CLL Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood by density gradient centrifugation using Ficoll-Paque (GE Healthcare, Chicago, IL, USA). CD19+ B cells, including MEC-1 cells, were purified by magnetic-activated cell sorting (MACS) using human B-cell isolation kit II or human CD19 MicroBeads (Miltenyi, Bergisch-Gladbach, Germany). Purification of primary CLL cells (CD19+ CD5+) and MEC-1 cells (GFP, CD19+) was performed using fluorescence-activated cell sorting (FACS) (BD Aria II, BD Bioscience, Franklin Lakes, NJ, USA). All antibodies are listed in Supplementary Table 3. Peripheral blood, spleen, and axillary lymph nodes were harvested per mouse. Organs were meshed through a 70 μm cell strainer in PBS buffer and erythrocytes were lysed using G-DEXTMIIb RBC Lysis Buffer (Intron Biotechnologies).
+ Open protocol
+ Expand
3

Primary B Cell Expansion Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
125 ml blood samples were processed within several hours of being drawn with EDTA to prevent clotting by TSRI normal blood donor services. PBMCs were purified by density gradient centrifugation on Lymphoprep (Alere technologies) in SepMate-50 (Stem cell technologies) tubes. B cells were positively purified from ACK treated, PBS washed PBMCs using human CD19 Microbeads (Miltenyi) according to the manufacturer’s instructions. Purified CD19 +B cells were immediately placed into culture at 0.5 × 106 cells/ml. Primary B cells were cultured in CD40L/IL-4 B cell expansion media (Miltenyi), with antibiotics (pen/strep), according to the manufacturer’s instructions. Cells were kept between 0.5 and 1.5 × 106 cells/ml at 37°C in a humidified incubator with 5.0% CO2. Media was replaced every four days and B cell clusters disrupted by pipetting at the time of media replacement. CFSE staining (CellTrace) was performed according to the manufacturer’s instructions.
+ Open protocol
+ Expand
4

Enrichment and Sorting of SARS-CoV-2 Specific Memory B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
B cells, enriched from PBMCs with human CD19 MicroBeads (Miltenyi), were incubated with 2 μg/ ml flag-tagged S protein or mixture of flag-tagged S protein (Genscript, Cat. Z03481) and His-tagged RBD (Chen et al., 2020 (link)) on ice for 30 min. Cells were then washed with 2% fetal bovine serum (FBS) (Hyclone) in PBS and stained with mixture of anti-human IgG (Percpcy5.5; Biolegend Cat. 410710), anti-human IgD (FITC; Biolegend Cat. 348205), anti-human IgM (Bv605; Biolegend Cat. 314524), anti-CD27 (APCcy7; Biolegend Cat. 356404). A mixture of PE- and APC-conjugated anti-flag antibodies (Biolegend Cat. 637309 and 637307) was also added for gating S-specific double positive cells, or a mixture of PE-conjugated anti-His (Biolegend Cat. 362603) and APC-conjugated anti-flag, for S positive and RBD negative cells. Memory B cells were gated on DAPI-CD19+IgM-IgD-IgG+CD27+. Individual S double positive or S+RBD- cells were sorted with a FACSAria Fusion (BD Biosciences) into each well of 96-well microplates containing 4 μl/well of lysis buffer (0.5X PBS, 10 mM dithiothreitol, and 4U RNaseOUT). Lysed cells were immediately frozen and stored at −80°C until use.
+ Open protocol
+ Expand
5

Autologous B Cell Culture and Expansion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Autologous B cells were isolated from fresh or thawed PBMC by positive selection using human CD19 microbeads (Miltenyi, cat# 130-050-301) according to the manufacturer’s instructions. Isolated B cells were cultured with irradiated (5000Gy) NIH 3T3 cells expressing human CD40L for 7 days in B cell medium supplemented with 200U/ml human IL-4 (Peprotech) as described.(Tran et al., 2014 (link)) B cells were subsequently harvested and restimulated with 3T3 CD40L and fresh medium every 3 days. B cells were pulsed with peptides and used in assays at day +3 of stimulation 2 or 3.
+ Open protocol
+ Expand
6

Isolation of BM CD19+ and CD138 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We collected samples from all 56 subjects and we isolated mononuclear cells (MNCs) from the BM blood samples (range, 4–6 mL) using Ficoll density gradient centrifugation at 800 rpm for 20 min. Immediately after, we selected BM CD19+ cells using Human CD19 MicroBeads; afterward, CD138 cells were positively isolated from the collected CD19− cells using Human CD138 Micro Beads according to the manufacturer’s instructions (Miltenyi Biotec, Milan, Italy) [17 (link)].
+ Open protocol
+ Expand
7

Isolation and Characterization of B-cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions of CD19+ B lymphocytes from each FL biopsy were isolated by physical disruption and magnetic-assisted cell sorting (MACS, Human CD19 Microbeads, Miltenyi, Bergisch Gladbach, Germany). PBB were isolated from blood samples by negative sorting (Human B cell Isolation Kit II, Miltenyi) and immediately processed (resting PBB) or subjected to in vitro activation using IL4, anti-CD40, IgM, and IgD (activated PBB). Tonsillar tissues were mechanically disrupted and digested with collagenase for 1h. GC-B cells were isolated by MACS (CD19+ sorting) and flow cytometry to sort CD10+CD44loCXCR4+ (CB) and CD10+CD44loCXCR4 (CC) populations from tonsil (Caron et al., 2009 (link)).
+ Open protocol
+ Expand
8

Fractionation and Purification of Blood Cell Types

Check if the same lab product or an alternative is used in the 5 most similar protocols
Citrated peripheral blood was collected and fractionated over the Ficoll-Histopaque (Sigma, St. Louis, MO, USA). The platelet rich plasma (PRP) layer was removed and platelets were pelleted and resuspended in Beads Buffer (BB; PBS with 0.5% w/v of bovine serum albumin and 2.5 m Methylenediaminetetraacetic acid final concentration). Leukocytes were removed with MACS Human CD45 microbeads reagents (Miltenyi Biotec, Auburn, CA, USA) [39] . The mononuclear cell layer was recovered, washed and re-suspended in BB for isolation of T-cells and B-cells using human CD3 and human CD19 microbeads (MiltenyiBiotec, Auburn, CA, USA), respectively. The buffy coat atop the red blood cells was removed, washed with PBS, treated with Erythrocyte lysis buffer (Qiagen, Hilden, Germany), pelleted and resuspended in BB. Granulocytes were isolated using MACS Human CD15 microbeads (MiltenyiBiotec). Lastly, erythrocytes were isolated from the lowest Ficoll-Histopaque layer by double immunodepletion of white blood cells and granulocytes using Human CD45 and CD15 microbeads. Cell purity was assessed on a FACScan (Becton Dickinson, Franklin Lakes, NJ, USA) using FlowJo 8.5.3 software (Tree Star Inc., Ashland, OR, USA).
+ Open protocol
+ Expand
9

Isolation and Characterization of Cell Samples for CLL Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Healthy blood from anonymous donors were obtained with written consent from the Department of Transfusion Medicine, NIH Clinical Center, and analyzed with the approval of the ethical review committee of the NIH. CLL patient samples were obtained after written informed consent in accordance with the Declaration of Helsinki, applicable federal regulations, and requirements from the National Heart, Lung, and Blood Institute Institutional Review Board. The clinical study is registered at clinicaltrials.gov as NCT00923507 and NCT00071045. Peripheral blood mononuclear cells (PBMCs) were isolated from buffy coats using Ficoll-Hypaque (GE Healthcare Biosciences, Pittsburgh, PA) by gradient centrifugation. The following cell lines were cultured in complete media and used as a target in assays: CCRF-CEM, MEC1, Nalm6 and U937. MEC1-001 and MEC1-002 were descripted previously (17 (link)), and were tested negative for mycoplasma contamination. Both B- and T- cells were isolated from buffy coat using human CD19 microbeads and pan T cell isolation kit (Miltenyi Biotech, Auburn, CA). Human CD34+ hematopoietic stem cells (HSCs) were purchased from StemCell Technologies (Vancouver, BC, Canada). MEC1-001-Siglec-6 Transgenic (TG) cells we generated by retroviral transduction with pEV-Thy1.1-hSiglec-6. The CD19-CAR construct corresponds to the previously described MSGV-FMC63-28Z (19 (link)).
+ Open protocol
+ Expand
10

Isolation and Sorting of T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experiments using primary cells were conducted at the MSKCC, using institutional-review-board (IRB)-approved protocols. PBMCs were isolated from whole blood of two different healthy donors using Ficoll-Paque PLUS (GE Healthcare, Chicago, IL, USA). B cells were separated from PBMCs by using human CD19 microbeads, according to the manufacturer’s manual (Miltenyi Biotec, Bergisch Gladbach, Germany). The B cell-depleted PBMCs were then subjected to fluorescence-activated cell sorting (FACS) using a FACSAria (BD Biosciences, San Jose, CA, USA) high-speed cell sorter to obtain CD5+ cells. These cells were then sorted to collect CD4+ and CD8+ T cell populations that were subsequently pooled together to be used in experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!